LEADIANT BIOSCIENCES

What this means for you

Registered since 11 Apr 2017. The owner can stop confusingly similar uses in the classes it covers.

Record

Serial number

86943755

Registration number

5179368

Mark type

Stylized text

Filed

17 Mar 2016

Published for opposition

24 Jan 2017

Registered

11 Apr 2017

Attorney of record

Michael N. Mercanti

Goods and services

• Class 005 — Pharmaceuticals: Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the respiratory system, the musculoskeletal system, the genitourinary system, for the treatment of nephrological disorders, inflammatory disorders, cancer and rare diseases, for use in dermatology, in hematology, in oncology, in transplantation, in ophthalmology, for use in gastroenterological areas and the prevention and treatment of ocular disorders or diseases; dietary supplements for humans and animals

Owner

• LEADIANT BIOSCIENCES LIMITED, London, GB
• LEADIANT BIOSCIENCES LIMITED, London, GB
• Sigma-Tau Rare Disease Limited, London, GB

Prosecution history

• 02 Dec 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
• 02 Dec 2025 — TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
• 02 Dec 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
• 02 Dec 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
• 17 Oct 2022 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
• 17 Oct 2022 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
• 12 Oct 2022 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
• 14 Apr 2022 — TEAS SECTION 8 & 15 RECEIVED
• 11 Apr 2022 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
• 28 Feb 2018 — CORRECTION UNDER SECTION 7 - PROCESSED
• 18 Sept 2017 — TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
• 11 Sept 2017 — POST REGISTRATION ACTION MAILED - SEC. 7
• 01 Aug 2017 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
• 17 Jul 2017 — OTQR WITHDRAWAL FROM PUBLICATION
• 06 Jul 2017 — POST REGISTRATION ACTION CORRECTION